These results indicated that esophageal cancer patients with high AKR1C1/C2 expression may be more susceptible to EDHB, thus providing potential guidance for the chemoprevention and clinical treatment of ESCC. Here, AKR1C1 is linked to esophageal squamous cell carcinoma.